Results 21 to 40 of 102
< Previous  Page 2 of 6  Next >
TypeTitleAuthor(s)YearViews
A woman with hypophosphataemia and raised alkaline phosphatase.Lam, JK; Lam, KS; Tan, KC; Chow, WS; Tso, AW; Kung, AW2010537
 
An "unforeseen" complication of urinary tract infection in a patient with diabetes.Yuen, MM; Tam, TC; Lau, WW; Chan, JF; Chow, WS; Lam, KS201063
 
Plasma Osteoprotegerin Correlated with Endothelium-Independent Vasodilation in Type 2 DiabetesChow, WS; Tse, HF; Tso, AWK; Xu, A; Tam, S; Fong, CHY; Lam, KSL2009106
 
Role of two novel adipokines in the prediction of coronary atherosclerosisOng, LHY; Tso, AWK; Mak, HKF; Xu, A; Fong, CHY; Yeung, DCY; Lam, JKY; Chow, WS; Wat, NMS; Khong, PL; Lam, KSL2009116
 
Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patientsYeung, DCY; Xu, A; Tso, AWK; Chow, WS; Wat, NMS; Fong, CHY; Tam, S; Sham, PC; Lam, KSL2009205
 
Atorvastatin Induces the Expression of Soluble Receptor for Advanced Glycation End ProductsTam, HL; Shiu, SWM; Chow, WS; Wong, Y; Betteridge, DJ; Tan, KCB2009185
 
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humansZhang, X; Yeung, DCY; Karpisek, M; Stejskal, D; Zhou, ZG; Liu, F; Wong, RLC; Chow, WS; Tso, AWK; Lam, KSL; Xu, A2008162
 
The effect of intragastric balloon placement on weight loss and type 2 diabetes controlChan, AOO; Chow, WS; Lam, KF; Hsu, A; Hung, I; Chan, P; But, D; Seto, WK; Lam, KSL2008176
 
Adipose tissue and the metabolic syndrome: Focusing on adiponectin and several novel adipokinesTso, AWK; Xu, A; Chow, WS; Lam, KSL2008146
 
Effect of atorvastatin on serum soluble receptor for advanced glycation end products in type 2 diabetesTam, HL; Shiu, SWM; Chow, WS; Wong, Y; Tan, KCB2008149
 
Innovative risk stratification model for high-risk diabetic patients in a tertiary referral centre – triage of the triagedWat, NMS; Tan, KCB; Chow, WS; Tse, PM; Wong, K; Leung, E; Hung, V; Leung, SK; Yee, A; Leung, CY; Lam, KSL2007153
 
Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetesTan, KCB; Chow, WS; Tso, AWK; Xu, A; Tse, HF; Hoo, RLC; Betteridge, DJ; Lam, KSL2007131
 
Adiponectin mediates the suppressive effect of rosiglitazone on plasminogen activator inhibitor-1 productionHoo, RLC; Chow, WS; Yau, MH; Xu, A; Tso, AWK; Tse, HF; Fong, CHY; Tam, S; Chan, L; Lam, KSL2007153
 
Ppar-γ Agonist Induced-suppression Of Plasminogen Activator Inhibitor-1 Production Is Mediated Through Adiponectin.Hoo, RLC; Chow, WS; Tse, HF; Fong, HY; Tam, S; Chan, LCB; Lam, KSL200775
 
Adiponectin mediates the suppressive effect of rosiglitazone on PAI-1 productionChow, WS; Hoo, RLC; Yau, MH; Xu, A; Tse, HF; Tso, AWK; Fong, HY; Tam, S; Chan, L; Lam, KSL200791
 
Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humansWang, Y; Lam, KSL; Kraegen, EW; Sweeney, G; Zhang, J; Tso, AWK; Chow, WS; Wat, NMS; Xu, JY; Hoo, RLC; Xu, A2007211
 
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humansZhang, X; Yeung, CY; Wong, LC; Chow, WS; Xu, A; Lam, KSL200790
 
PPAR-γ agonist induced-suppression of plasminogen activator inhibitor-1 production is mediated through adiponectin.Hoo, RLC; Chow, WS; Yau, MH; Xu, A; Tse, HF; Tso, AWK; Fong, HY; Tam, S; Chan, L; Lam, KSL200781
 
Adipocyte fatty acid binding protein as a potential circulating metabolic hormone: clinical and functional studies.Lam, KSL; Tso, AWK; Chow, WS; Hoo, RLC; Zhang, J; Lam, CW; Xu, A200783
 
Hypoadiponectinemia as a predictor for the development of hypertension: A 5-year prospective studyChow, WS; Cheung, BMY; Tso, AWK; Xu, A; Wat, NMS; Fong, CHY; Ong, LHY; Tam, S; Tan, KCB; Janus, ED; Lam, TH; Lam, KSL2007175
 
< Previous  Page 2 of 6  Next >
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download